The upregulation of ANP32A in AD may be a consequence of increased transcription factors C/EBPβ, suggesting that the upregulation of C/EBPβ may represent a key role leading to ANP32A overexpression, followed by histone acetylation and impaired cognition. Here, CEBPB is linked to Alzheimer disease.